龙脷平喘膏抗哮喘大鼠气道炎症作用及机制

来源 :中国实验方剂学杂志 | 被引量 : 0次 | 上传用户:ytfeng
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨龙脷平喘膏对发作期小儿哮喘气道炎症的影响。方法:48只大鼠按体重均衡随机分为空白对照组、模型组、地塞米松组(1 mg·kg-1)、龙脷平喘膏高、中、低剂量组(74.8,37.4,18.7 g·kg-1),每组8只。采用卵清蛋白(OVA)复制哮喘大鼠模型,连续给药1周,记录大鼠过敏性鼻炎症状,取鼻黏膜和肺组织,观察鼻黏膜及肺组织病理形态变化,并检测肺组织炎症细胞凋亡率和原癌基因Fas(Fas mRNA),B细胞淋巴瘤/白血病2基因(Bcl-2 mRNA)的表达。结果:除空白组外,其他各组在引发过敏性哮喘的同时均诱发了不同程度的过敏性鼻炎症状,且模型组鼻黏膜和肺组织均见嗜酸粒细胞浸润及相似的病理形态学改变;与空白组比较,模型组大鼠搔鼻和喷嚏的次数显著增多(P<0.01);与模型组比较,龙脷平喘膏能明显减少哮喘大鼠搔鼻和喷嚏的次数(P<0.01)。与空白组比较,模型组大鼠肺组织中炎症细胞凋亡率显著降低(P<0.01);与模型组比较,龙脷平喘膏高、中剂量组大鼠肺组织中炎症细胞凋亡率明显升高(P<0.05),且肺组织中促炎症细胞凋亡的调控基因Fas mRNA阳性表达率显著升高(P<0.01),抑制炎症细胞凋亡的调控基因Bcl-2 mRNA阳性表达率则显著下降(P<0.01)。结论:龙脷平喘膏能明显抑制哮喘大鼠气道炎症,机制可能与其逆转Fas/Bcl-2失衡,促进炎症细胞凋亡有关。 Objective: To investigate the effect of Longji Pingchuan Ointment on airway inflammation in infantile asthma. Methods: Forty-eight rats were randomly divided into control group, model group, dexamethasone group (1 mg · kg -1), Longjian Pingchuan Paste high, middle and low dose groups (74.8, 37.4, 18.7 g · kg-1), 8 in each group. Asthma rat model was induced by ovalbumin (OVA) for 1 week. The symptoms of allergic rhinitis in rats were recorded. The nasal mucosa and lung tissue were taken for observation of pathological changes of nasal mucosa and lung tissue. The apoptosis rate and the expression of Fas (Fas mRNA) and Bcl-2 mRNA. Results: In addition to the blank group, the other groups all induced allergic rhinitis symptoms at the same time, and eosinophil infiltration and similar histopathological changes were observed in the nasal mucosa and lung tissue of the model group ; Compared with the blank group, the number of nasal and sneezing in the model group was significantly increased (P <0.01); Compared with the model group, Longji Pingchuan Cream can significantly reduce the number of nasal and sneezing in asthmatic rats (P <0.01 ). Compared with the blank group, the apoptotic rate of inflammatory cells in the lung tissue of the model group was significantly decreased (P <0.01). Compared with the model group, the apoptosis rate of inflammatory cells in the lung tissue of Longji Pingchuan Ointment group (P <0.05), and the positive expression rate of Fas mRNA in lung tissue was significantly higher (P <0.01). The positive rate of Bcl-2 mRNA expression in the control group Decreased significantly (P <0.01). Conclusion: Longji Pingchuan Paste can significantly inhibit the airway inflammation in asthmatic rats, which may be related to reversing the imbalance of Fas / Bcl-2 and promoting the apoptosis of inflammatory cells.
其他文献
负责中国区业务的康明斯集团副总裁石内森在接受中国国际电视台(CGTN)采访时表示,中国是康明斯关键的运营市场,康明斯多年来在中国一直秉持本土化经营战略:员工、供应链、生
从三个方面,即:西药与中成药联合治疗、西药与生脉注射液、与参麦注射液、黄芪注射液,西药与中药成方联合治疗、西药与中药自拟方联合治疗等对中西医结合治疗扩张型心肌病的治疗
ue*M#’#dkB4##8#”专利申请号:00109“7公开号:1278062申请日:00.06.23公开日:00.12.27申请人地址:(100084川C京市海淀区清华园申请人:清华大学发明人:隋森芳文摘:本发明属于生物技
通过对钢筋混凝土蓄水池的施工介绍,系统论述了这种特殊构筑物的施工要求。为确保施工质量,防止出现水池渗漏等质量问题,在阐明科学施工方法基础上,明确施工关键部位,强调施工注意
从近几年制造业信息化建设的重点来看,相当一部分企业已经完成了诺兰模型的“控制阶段”,进入了“集成阶段”(两化融合的“综合集成阶段”)。很多企业发现,要跨越这个阶段十